BackTheravance Biopharma Overview

Theravance Biopharma Current Cash

Theravance Biopharma's current cash is $220M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$219.77M
↓ 22.05% YoYΔ $-62.16M vs prior year quarter

Peer trimmed avg / median

Loading

Theravance Biopharma Current Cash History

Loading

Theravance Biopharma vs. peers: Current Cash Comparison

Loading

Theravance Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Theravance Biopharma (TBPH) FAQ

Theravance Biopharma (TBPH) currently reports a current cash of $220M as of June 2026. That compares with $280M in the prior-year period — down 22.0% year over year. Use the charts on this page to explore Theravance Biopharma's current cash history and peer comparisons.

Theravance Biopharma's current cash decreased from $280M to $220M — a 22.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theravance Biopharma reported $220M in current cash as of June 2026. That compares with $280M in the prior-year period — down 22.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Theravance Biopharma, and consider following TBPH for alerts when major investors trade the stock.

Theravance Biopharma is classified in the Healthcare sector. On current cash, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TBPH with unrelated industries.